期刊文献+

葡萄糖对MG63细胞株TRAIL表达的影响

Effects of glucose on expression of tumor necrosis factor-related apoptosis-inducing ligand in MG63 cells
下载PDF
导出
摘要 目的:观察在不同浓度葡萄糖环境下人成骨肉瘤MG63细胞株肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其护骨素(OPG)、护骨素配体(OPGL)的表达,探讨糖尿病骨质疏松症的发病机制。方法:用不同浓度葡萄糖(5.5、16.7、33.3mmol/L)分别刺激培养的MG63细胞24h,采用RT-PCR法检测TRAIL、OPG、OPGLmRNA的表达,以免疫组织化学法检测MG63细胞中TRAIL的表达及分布。结果:不同浓度葡萄糖环境的MG63细胞中TRAIL、OPGLmRNA的表达,均按照对照组、5.5mmol/L组、16.7mmol/L组、33.3mmol/L组的顺序递增(P<0.05),OPGmRNA的表达按照此顺序递减(P<0.05)。33.3mmol/L组TRAILmRNA的水平明显高于对照组[(1.004±0.070)vs(0.740±0.023),P<0.05],TRAIL免疫反应阳性物质密度也明显高于对照组。结论:高糖环境可能导致成骨细胞中TRAIL和OPGL表达增多,OPG表达减少。这可能是糖尿病骨质疏松症的重要发病机制之一。 Objective: To observe the effects of different concentrations of glucose on the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), osteoprotegerin (OPG), and the ligand of osteoprotegerin (OPGL) in osteosarcoma MG63 cells, so as to assess the role of glucose in pathogenesis of diabetic osteoporosis. Methods: MG63 cells were incubated with glucose at the concentrations of 5.5,16.7,33.3 mmol/L for 24 h. The expression of TRAIL, OPG and OPGL mRNA were examined by RT-PCR. Expression and distribution of TRAIL in MG63 cells were investigated by immunohistochemical method. Results: The mRNA expression of TRAIL and OPGL in MG63 cells increased in the order of control group, 5.5,16.7,33.3 mmol/L glucose groups( P〈 0.05), and the expression of OPG mRNA decreased in the same order(P〈0.05). TRAIL mRNA level in 33. 3 mmol/L glucose group was significantly higher than that in the control group [(1. 004±0. 070) vs (0. 740±0. 023),P〈0.05] and the expression of TRAIL was stronger than that in the control group. Conclusion: High concentration of glucose can lead to increased expression of TRAIL and OPGL in osteoblasts and decreased expression of OPG, which may be one of the key pathogenetic factors of diabetic osteoporosis.
机构地区 解放军第
出处 《第二军医大学学报》 CAS CSCD 北大核心 2007年第7期771-774,共4页 Academic Journal of Second Military Medical University
关键词 糖尿病 骨质疏松 葡萄糖 MG63细胞 肿瘤坏死因子相关凋亡诱导配体 diabetes mellitus osteoporosis glucose MG63 cell tumor necrosis factor-related apoptosis-inducing ligand
  • 相关文献

参考文献11

  • 1廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611.
  • 2Morrison B,Tang Z,Jacobs B,et al.Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-β-induced apoptosis in ovarian carcinoma[J].Biochem J,2005,385(Pt 2):595-603.
  • 3成诗银,张惠中,陈剑秋,张丽,韩明坤.肿瘤细胞内特异表达TRAIL载体的构建及其在喉癌细胞株Hepa2中的表达[J].第四军医大学学报,2005,26(12):1108-1111. 被引量:4
  • 4Matsuda T,Almasan A,Tomita M,et al.Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines[J].J Virol,2005,79:1367-1378.
  • 5Ishikawa E,Nakazawa M,Yoshinari M,et al.Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice[J].J Virol,2005,79:7658-7663.
  • 6付建芳,姬秋和,黄威权,张南雁.桥本甲状腺炎中TRAIL及其死亡受体DR4,DR5的表达[J].第四军医大学学报,2002,23(10):920-923. 被引量:15
  • 7Naoshi O,Daichi C,Naoto K,et al.Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover[J].J Clin Invest,2000,105:935-943.
  • 8Sanlioglu A D,Dirice E,Aydin C,et al.Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells[J].BMC Cancer,2005,5:54.
  • 9Pritzker L B,Scatena M,Giachelli C M.The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival[J].Mol Biol Cell,2004,15:2834-2841.
  • 10Bell N H.RANK ligand and the regulation of skeletal remodeling[J].J Clin Invest,2003,111:1120-1122.

二级参考文献9

  • 1Gazitt Y.TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells[J].Leukemia,1999:131817-1824.
  • 2Jo M,Kim TH,Seol DW,et al.Apoptosis induced in normal human hepatocytes by tumor necrosis factor—related apoptosis—inducingligand [J].Nat Med,2000:6:564—567.
  • 3Lamhamedi-Cherradi SE,Zheng S,Magusehak K,et al.Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice[J].Nat lmmunol,2003:4:255—260.
  • 4Taimr P,Higuchi H,Kocova E,et al.Activated stettate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis[J].Hepatology.2003:3787—95.
  • 5Takakma M,Kvo S,Kanaya T,et al.Cloning of hunmn telomerase catalytie subunit(hTERT) gene promoter and identification of proximat core pronloter sequences essential for transcriptional activation in immortalized and cancer cells[J].Cancer Res,1999:59:551-557.
  • 6Mariani SM,Krammer PH.Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and Blymphocyte linege[J].Eur J Immunol,1998:28(3):973—982.
  • 7Gonzalez-Quexedo R, de Juan C, Massa MJ, et al.Detection of telomerase activity in human carcinomas using a trap-ELISA method:Correlation with hTR and hTERT expression [J].2000:16(3) :623 -628.
  • 8Luzar B, Potjak M, Marin IJ, et al. Telomerase reactivation is an early event in laryngeal carcinogenesis [J].Mod Pathol,2003:16(9) :841-848.
  • 9刘剑锋,陶泽璋,杨强,肖伯奎,詹汉章.头颈部鳞癌及癌旁组织端粒酶活性检测[J].临床耳鼻咽喉科杂志,2000,14(6):246-247. 被引量:4

共引文献678

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部